Fraser Wares

Senior Consultant (PMDT)

Fraser Wares is a trained Public Health Physician, working at KNCV as a Senior Consultant (PMDT) since March 2016. Under the Challenge TB project (up to October 2019), his main focus was on the “New Drugs and Regimens Initiative” for drug-resistant TB (DR-TB) patients. Since then his focus has continued to be on the introduction of new drugs and regimens for DR-TB patients, especially the 6-9 month all oral BPaL regimen.

He has worked on TB control for over 25 years in Africa, Asia and Europe, including 14 years of working for the World Health Organisation’s (WHO) Global TB Programme (8 years in India and 6 years in Geneva, Switzerland). For the last 15 years, his area of interest and work has focused on DR-TB and the programmatic management of DR-TB (PMDT), and supporting countries to expand their PMDT services and care, via contributing to global level policy development, in-country capacity building activities, and via the work of the Green Light Committees and the Global Drug Resistant TB Initiative. He has co-authored over 100 publications in international and national scientific journals, and textbooks, and has contributed to the development of a number of WHO global policy documents, mainly related to PMDT and DR-TB.

Recent publications

Tesema E, Wares F, Bedru A, Negeri C, Molla Y, et al. Experiences of introducing new drugs for drug-resistant TB at the ALERT Hospital, Addis Ababa, Ethiopia, 2017–2019. Public Health Action 2021 June; 11(2): 50–52. Full paper

Monedero-Recuero I, Gegia M, Wares F, Chadha S, Mirzayev F. Situational analysis of 10 countries with a high burden of drug-resistant tuberculosis 2 years post-UNHLM declaration: progress and setbacks in a changing landscape. IJID 2021;108: 557–567. Full paper

Linh NN, Wares F, Cocozza AM, Uplekar M, Raviglione M. No universal access to drug-resistant tuberculosis care without engaging all health care providers. Int J Tuberc Lung Dis 2020 1;24(1):118-23. Abstract

Ruda C, Wares F, Hiruy N, et al. Streamlining TB Infection Control and Intensifying TB Screening in Ethiopian Health Facilities. J Med-Clin Res & Rev. 2020;4(3): 1-5. Full article

CG Edwards, F Wares, Dravniece, A. Gebhard, E Tiemersma, E van der Grinten et al. Introducing bedaquiline: experiences from the Challenge TB project. Int J Tuberc Lung Dis. 2020;24(10):1046-1053. Abstract/Full article


read all the KNCV publications

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi


De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.